Intercept Pharmaceuticals Inc
ICPT
Market Cap$794.69M
Close$
$21.67
14% upside
Current Fair Value
14% upsideUndervalued by 14% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $794.69 Million |
|---|---|
| Enterprise Value | $915.81 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.41 |
| Beta | 0.88 |
| Outstanding Shares | 41,792,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -91.78 |
|---|---|
| PEG | 90.83 |
| Price to Sales | 3.17 |
| Price to Book Ratio | 19.0 |
| Enterprise Value to Revenue | 3.18 |
| Enterprise Value to EBIT | -13.44 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 3.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data